查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1992861

球囊导管市场：2026-2032年全球市场预测（按应用、产品类型、材质、最终用户和直径范围划分）

Balloon Catheter Market by Application, Product Type, Material, End User, Diameter Range - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，球囊导管市场价值将达到 36.5 亿美元，到 2026 年将成长至 39.3 亿美元，到 2032 年将达到 59.1 亿美元，复合年增长率为 7.10%。

主要市场统计数据
基准年 2025 36.5亿美元
预计年份：2026年 39.3亿美元
预测年份 2032 59.1亿美元
复合年增长率 (%) 7.10%

一篇全面的说明，探讨了不断变化的临床需求和治疗过程如何重新定义球囊导管技术和治疗环境。

目前球囊导管的发展现况取决于临床需求、医疗设备的逐步创新以及不断演进的诊疗路径的交会点。近年来，临床医生和製造商紧密合作，致力于改善导管设计，以提高置入便利性、扩大可及血管范围并提升手术安全性。随着影像技术和辅助性治疗的日益成熟，球囊导管的功能已不再局限于扩张血管腔；它们如今已成为药物输送、病变治疗和目标血管重塑的平台。这些变化是由人口老化和慢性血管疾病盛行率上升等人口结构变化所驱动，导致多个专科的球囊导管手术量不断增加。

材料创新、平台改进和影像技术的整合如何改变球囊导管治疗的路径和操作流程？

在球囊导管产业，突破性的变革正在加速提升设备效能，并增强其与临床工作流程的互通性。材料科学的进步，特别是热可塑性橡胶和高强度聚合物的进步，使得在保持爆破强度的同时实现导管的超薄设计成为可能，从而改善了导管在弯曲解剖结构中的导航性能。同时，快速交换平台的改进优化了单人操作流程中的导管操作，使特定手术在门诊手术中心和专科诊所的实施更加可行。除了硬体的改进之外，药物涂层和药物释放型球囊技术的兴起也降低了血管再阻塞，减少了对永久性植入的需求，并重塑了治疗流程。

评估美国在 2025 年实施的累积关税如何重组了整个球囊导管生态系统的供应链、製造地和采购方式。

美国自2025年起实施的累积关税已在全球医疗设备零件供应链中造成明显摩擦，其中包括球囊导管的原料和子组件。先前依赖跨境采购聚合物、导管轴和配件材料的製造商正面临更高的接收成本，被迫重新评估供应商合约并调整总接收成本模型。为此，一些医疗设备製造商正在启动近岸外包和在岸外包策略，以降低关税风险并缩短前置作业时间。然而，这些转型需要资本投入和重新认证，短期内可能会对营业利润率造成压力。

详细的細項分析揭示了临床应用、平台设计、材料、医疗环境和内径规格如何驱动产品差异化和普及。

从临床应用、器械结构、材料成分、终端用户环境和尺寸范围等角度进行详细的市场細項分析，揭示了不同产品的独特性能和扩散动态。就应用领域而言，心血管应用仍然是核心，包括冠状动脉成形术和周边心臟介入治疗，这些手术需要精确的球囊顺应性和轮廓控制。神经血管手术需要超低轮廓和柔性设计，以便穿过脑血管。颈动脉、下肢和肾动脉病变的周边血管介入治疗通常需要更大直径和不同推播特性的球囊。此外，在泌尿系统应用中，生物相容性和扭矩控制是进入泌尿生殖系统的首要考虑因素。

美洲、欧洲、中东、非洲和亚太地区的需求模式和製造业实力差异如何影响各地区的商业化和生产策略？

球囊导管领域的区域趋势是需求侧临床实务模式和供应侧製造地共同作用的结果。在美洲，心血管和周边血管介入治疗量庞大，加之完善的医保体系和成熟的医院系统，推动了针对复杂解剖结构而开发的新型创新技术和器械的快速普及。商业环境强调全面的临床证据和上市后註册研究以支持产品的推广应用，而进行特定球囊介入治疗的门诊诊所也在不断扩展。

策略竞争分析，描述了现有设备组合、专家创新者和製造合作伙伴如何透过合作和差异化来争夺竞争优势。

球囊导管领域的竞争格局呈现出多元化的特点，既有老牌医疗设备巨头，也有专注于创新领域的专业企业，还有灵活敏捷的契约製造。市场参与企业在多个方面竞争，包括平台的多功能性、材料科学带来的差异化优势、临床证据以及供应链的韧性。老牌製造商通常利用其广泛的心血管产品组合来整合解决方案并构建一体化的手术方案，而专注于特定领域的企业则致力于突破性涂层、新型球囊形状或超低轮廓输送系统，以在特定的临床细分市场中占据主导地位。

为医疗设备製造商提供切实可行的策略建议，以确保供应链的韧性，加快证据的产生，并扩大在所有医疗保健机构中的应用。

产业领导者应优先考虑多管齐下的策略，以平衡短期业务永续营运和长期创新。首先，他们应重新评估并优化供应商网络，以降低关税和前置作业时间风险。在条件允许的情况下，他们应认证多家材料供应商，并考虑在与需求中心相符的区域製造地。其次，他们应加大对材料和涂层的研发投入，以降低製造复杂性并维持临床性能，同时设计具备快速切换和快速更换能力的平台，以满足所有医疗机构的需求。

采用严谨的混合方法研究途径，结合专家访谈、临床文献、医疗设备註册和供应链分析，以检验策略见解。

为确保可靠性和有效性，本报告的研究采用了交叉检验的一手和二手调查方法。一手研究包括对介入性心臟病专家、介入神经放射学、血管外科医生、医院和门诊手术中心的采购经理以及医疗设备製造商的研发和供应链主管进行结构化访谈。这些访谈提供了关于手术偏好、医疗设备性能权衡以及影响采购决策的因素的定性背景资讯。二级资讯来源包括同行评审的临床文献、医疗设备註册资讯、监管文件、专利趋势以及製造和材料技术概述，所有这些资料均用于支持一手研究的发现。

一份权威的综合分析报告，重点阐述了医疗设备创新、供应链韧性和临床证据之间的相互作用如何塑造未来的应用和治疗结果。

总之，球囊导管领域正步入一个实践创新期，其发展得益于材料技术的进步、平台的多功能性以及医疗服务环境的不断演变。能够将设计重点与实际手术流程和支付方期望相契合的製造商将获得商业性优势。同时，关税和贸易趋势等政策凸显了供应链弹性和区域製造策略的重要性，促使企业在成本控制和持续投入实证医学方面寻求平衡。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：球囊导管市场：依应用领域划分

  • 心血管系统
    • 冠状动脉成形术
    • 週边心臟治疗
  • 神经血管
  • 週边血管
    • 颈动脉
    • 下肢
    • 肾动脉
  • 泌尿系统

第九章：球囊导管市场：依产品类型划分

  • 越过电线
  • 快速交换

第十章：球囊导管市场：依材料分类

  • 尼龙
  • 佩巴克斯
  • 聚氨酯

第十一章 球囊导管市场：依最终用户划分

  • 门诊手术中心
  • 医院
  • 专科诊所

第十二章 依直径范围分類的球囊导管市场

  • 6毫米或以上
  • 3-6毫米
  • 小于3毫米

第十三章 球囊导管市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 球囊导管市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 球囊导管市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国球囊导管市场

第十七章：中国球囊导管市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Acrostak AG
  • Alvimedica Medical Technologies Inc.
  • B. Braun Melsungen AG
  • Balton Sp. z oo
  • Biosensors International Group, Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Endocor GmbH
  • Hexacath, Inc.
  • JOTEC GmbH
  • Medinol Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Oscor Inc.
  • QualiMed Innovative Medizinprodukte GmbH
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-1A1A064C008D

The Balloon Catheter Market was valued at USD 3.65 billion in 2025 and is projected to grow to USD 3.93 billion in 2026, with a CAGR of 7.10%, reaching USD 5.91 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.65 billion
Estimated Year [2026] USD 3.93 billion
Forecast Year [2032] USD 5.91 billion
CAGR (%) 7.10%

A comprehensive introduction exploring how clinical demand and care pathway evolution are redefining balloon catheter technology and procedural settings

The balloon catheter landscape sits at the intersection of clinical necessity, incremental device innovation, and evolving care pathways. Recent years have seen clinicians and manufacturers collaborate closely to refine designs that improve deliverability, expand vessel reach, and enhance procedural safety. As imaging modalities and adjunctive therapies mature, balloon catheters have become more than simple lumen-expanders; they function as platforms for drug delivery, lesion preparation, and targeted vessel remodeling. These shifts are driven by demographic realities, with aging populations and higher prevalence of chronic vascular conditions increasing procedural volumes across multiple specialties.

From a system perspective, the interplay between hospitals, ambulatory surgical centers, and specialty clinics is reshaping where and how balloon catheter procedures are performed. Payment models and care pathway optimization are steering straightforward interventions toward lower-cost sites while complex or high-risk cases remain concentrated in tertiary centers. Consequently, device designers face dual pressures: deliver robust clinical performance within constrained procedural times and adapt to the logistics and staffing profiles of a broader range of care settings. Taken together, the introduction underscores an era of precision-focused device evolution anchored in real-world clinical needs and operational pragmatism.

How material innovation, platform refinement, and imaging integration are collectively reshaping adoption pathways and procedural practice in balloon catheter care

Across the balloon catheter sector, transformative shifts are accelerating interoperability between device performance and clinical workflows. Advancements in materials science, particularly thermoplastic elastomers and high-strength polymers, have enabled thinner profiles with preserved burst strength, which in turn improve navigation through tortuous anatomy. Simultaneously, rapid exchange platform refinement has optimized catheter handling for single-operator workflows, making certain procedures more feasible in ambulatory surgical centers and specialty clinics. Parallel to hardware enhancements, the rise of drug-coated and drug-eluting balloon technologies has reframed treatment algorithms by reducing restenosis and limiting the need for permanent implants.

In tandem with clinical innovation, digitization and imaging integration are transforming pre-procedural planning and intra-procedural guidance. High-resolution intravascular imaging and enhanced fluoroscopic tools reduce reliance on operator experience alone, enabling broader adoption of advanced balloon techniques. Supply chain and manufacturing models are also shifting: there is increased vertical collaboration between polymer suppliers, contract manufacturers, and device OEMs to accelerate time to market and maintain quality control. Finally, regulatory pathways and post-market surveillance are becoming more dynamic, with real-world evidence playing a larger role in supporting expanded indications and reimbursement arguments. These combined forces are pushing the market toward greater specialization, modularity, and evidence-driven adoption.

Assessment of how cumulative U.S. tariffs introduced in 2025 reshaped supply chains, manufacturing footprints, and procurement behavior across the balloon catheter ecosystem

The imposition of cumulative tariffs in the United States beginning in 2025 has introduced measurable friction into global supply chains for medical device components, including balloon catheter raw materials and subassemblies. Manufacturers that previously relied on cross-border sourcing of polymers, catheter shafts, and ancillary materials have faced rising landed costs, prompting a reevaluation of supplier contracts and total landed cost modeling. In response, several device makers have initiated near-shoring and onshoring strategies to mitigate tariff exposure and shorten lead times, although such shifts require capital investment and requalification timelines that can compress operating margins in the near term.

Moreover, tariff-induced cost pressures have accelerated conversations about design-to-cost and material substitution, encouraging R&D teams to test alternative polymers and extrusion techniques that retain clinical functionality while lowering input costs. For healthcare providers, incremental price increases have influenced procurement behavior, with hospital purchasing groups negotiating more aggressively and ambulatory surgical centers weighing the value of premium device features against reimbursement realities. In sum, the tariff environment has not only affected pricing but has triggered strategic operational adjustments across manufacturing footprints, supplier relationships, and product development roadmaps, with consequences that will reverberate through procurement and clinical adoption decisions.

In-depth segmentation insights revealing how clinical application, platform design, materials, care settings, and diameter specifications drive product differentiation and adoption

Deep segmentation analysis uncovers distinctive performance and adoption dynamics when the market is viewed through clinical application, device architecture, material composition, end-user setting, and size range lenses. Application-wise, cardiovascular use remains a central focus, encompassing coronary angioplasty and peripheral cardiac interventions that demand precise balloon compliance and profile control; neurovascular procedures call for ultra-low profile and flexible designs to traverse cerebral vasculature; peripheral vascular interventions for carotid artery, lower limb, and renal artery lesions often require larger diameters and different pushability characteristics; and urology applications prioritize biocompatibility and torque control for genitourinary access.

From a product architecture perspective, over-the-wire platforms offer superior support and are preferred in complex or long lesions, whereas rapid exchange designs reduce procedure time and operator complexity, supporting diffusion into ambulatory settings. Material selection further stratifies performance: nylon provides predictable compliance and burst resistance; Pebax enables tunable flexibility and shaft stiffness gradients; and polyurethane offers abrasion resistance and patient comfort in certain anatomies. End-user segmentation shows distinct procurement drivers; hospitals focus on a broad portfolio to manage complex caseloads, ambulatory surgical centers emphasize efficiency and cost-per-case, and specialty clinics prioritize devices that simplify workflows for high-volume, low-complexity interventions. Diameter ranges also create product differentiation-above six millimeters necessitates robust tensile properties and balloon geometry optimized for larger vessel mechanics, three to six millimeters represents a high-volume clinical sweet spot across peripheral and cardiovascular domains, and up to three millimeters demands ultra-low profile construction and exceptional trackability for coronary and neurovascular insertions. Collectively, these segmentation lenses inform product R&D priorities, go-to-market strategies, and clinical training investments.

How distinct demand patterns and manufacturing strengths across the Americas, Europe Middle East and Africa, and Asia Pacific are shaping regional commercialization and production strategies

Regional dynamics in the balloon catheter field reflect a combination of demand-side clinical practice patterns and supply-side manufacturing concentrations. In the Americas, strong procedural volumes in cardiovascular and peripheral interventions are supported by established reimbursement frameworks and mature hospital systems, fostering rapid uptake of incremental innovations and device variants tailored to complex anatomies. The commercial environment favors comprehensive clinical evidence and post-market registries to support uptake, and ambulatory centers continue to expand the settings in which selected balloon interventions occur.

Across Europe, the Middle East, and Africa, variability in regulatory regimes and payer structures shapes market entry strategies and pricing negotiations. European markets place a premium on cost-effectiveness and robust clinical data, while certain Middle Eastern markets prioritize rapid access to novel technologies. In the Asia-Pacific region, a dual trend is apparent: manufacturing capability and supplier ecosystems have deepened, enabling scale and price competitiveness, while clinical adoption is accelerating in tertiary urban centers and select high-volume specialty hospitals. Emerging markets within the region exhibit increasing procedural volumes but require tailored value propositions for constrained healthcare budgets. These regional contrasts influence where companies locate production, how they structure clinical partnerships, and which product variants they prioritize for launch.

Strategic competitive analysis describing how established device portfolios, specialist innovators, and manufacturing partners are jockeying for advantage through alliances and differentiation

Competitive dynamics in the balloon catheter arena are characterized by a mix of legacy medical device leaders, specialized innovators, and agile contract manufacturers. Market participants are competing on multiple fronts: platform versatility, material science differentiation, clinical evidence, and supply chain resilience. Established manufacturers often leverage broad cardiovascular portfolios to bundle solutions and create integrated procedure offerings, while niche players concentrate on disruptive coatings, novel balloon geometries, or ultra-low profile delivery systems to win specialist clinical segments.

Strategic responses include targeted M&A to acquire complementary technologies, licensing agreements for proprietary polymer formulations or drug-eluting platforms, and partnerships with imaging and navigation providers to create combined solutions. Contract manufacturers and precision extrusion houses are gaining influence by enabling cost-effective prototyping and volume production, which lowers barriers for smaller innovators. Companies are also investing in lifecycle support-training programs, proctoring, and digital follow-up tools-to differentiate on clinical outcomes and physician experience. Overall, the competitive landscape rewards players who can synchronize technical differentiation with scalable manufacturing and evidence generation pathways.

Action-oriented strategic recommendations for device makers to secure supply chain resilience, accelerate evidence generation, and expand adoption across care settings

Industry leaders should prioritize a multi-dimensional strategy that balances near-term operational resilience with long-term innovation. First, reassess and optimize supplier networks to reduce tariff exposure and lead-time risk; where feasible, qualify multiple material suppliers and consider regional manufacturing nodes that align with demand centers. Second, direct R&D toward materials and coatings that preserve clinical performance while lowering manufacturing complexity, and concurrently design platforms that accommodate both over-the-wire and rapid exchange configurations to span care settings.

Third, invest in robust clinical evidence programs that address key payer concerns and demonstrate total cost of care benefits, particularly for adoption in ambulatory and specialty settings. Fourth, pursue flexible pricing and value-based contracting approaches to accommodate diverse reimbursement landscapes across regions. Fifth, strengthen partnerships with imaging and digital navigation vendors to enhance procedural success rates and physician preference. Finally, implement a structured market access playbook that aligns product portfolios by diameter range and clinical application, ensures targeted training and proctoring resources, and embeds supply chain contingencies into commercial forecasting. These coordinated actions will help organizations mitigate policy-driven cost shocks while accelerating sustainable adoption.

A rigorous mixed-methods research approach combining expert interviews, clinical literature, device registries, and supply chain analysis to validate strategic insights

The research underpinning this report integrates cross-validated primary and secondary methods to ensure robustness and relevance. Primary research involved structured interviews with interventional cardiologists, neurointerventionalists, vascular surgeons, procurement leaders from hospitals and ambulatory surgical centers, and senior R&D and supply chain executives from device firms. These conversations provided qualitative context on procedural preferences, device performance trade-offs, and procurement decision drivers. Secondary sources included peer-reviewed clinical literature, device registries, regulatory filings, patent landscapes, and manufacturing and materials technical briefs, all synthesized to corroborate primary findings.

Data triangulation was employed to validate thematic insights, with contradictory inputs reconciled through follow-up expert validation. The methodology also included scenario analysis to evaluate the operational implications of tariff changes and supply chain reconfiguration. Limitations are acknowledged: the analysis focuses on structural and technical trends rather than numerical market sizing, and regional heterogeneity can produce local variations that warrant targeted follow-up. Nonetheless, the approach yields actionable, evidence-based perspectives suitable for strategic planning and product development prioritization.

A conclusive synthesis emphasizing the interplay between device innovation, supply chain resilience, and clinical evidence in shaping future adoption and outcomes

In conclusion, the balloon catheter domain is undergoing a period of pragmatic innovation shaped by materials advances, platform versatility, and evolving care delivery settings. Manufacturers that align design priorities with real-world procedural workflows and payer expectations will gain commercial advantage. Simultaneously, policy and trade dynamics such as tariffs have highlighted the importance of supply chain agility and regional manufacturing strategies, prompting companies to balance cost containment with sustained investment in evidence generation.

Looking forward, success will depend on integrating technical differentiation-whether through material innovation, coatings, or delivery mechanics-with scalable manufacturing, targeted clinical studies, and tailored market access plans. Providers and device makers that collaborate on training, procedural standardization, and outcome measurement will be best positioned to demonstrate value and broaden the appropriate use of balloon catheter technologies across care settings. The cumulative effect will be a more resilient, evidence-driven marketplace that delivers improved patient outcomes while addressing operational and economic constraints.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Balloon Catheter Market, by Application

  • 8.1. Cardiovascular
    • 8.1.1. Coronary Angioplasty
    • 8.1.2. Peripheral Cardiac Procedures
  • 8.2. Neurovascular
  • 8.3. Peripheral Vascular
    • 8.3.1. Carotid Artery
    • 8.3.2. Lower Limb
    • 8.3.3. Renal Artery
  • 8.4. Urology

9. Balloon Catheter Market, by Product Type

  • 9.1. Over The Wire
  • 9.2. Rapid Exchange

10. Balloon Catheter Market, by Material

  • 10.1. Nylon
  • 10.2. Pebax
  • 10.3. Polyurethane

11. Balloon Catheter Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Balloon Catheter Market, by Diameter Range

  • 12.1. Above 6 Millimeters
  • 12.2. 3 To 6 Millimeters
  • 12.3. Less Than 3 Millimeters

13. Balloon Catheter Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Balloon Catheter Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Balloon Catheter Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Balloon Catheter Market

17. China Balloon Catheter Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Acrostak AG
  • 18.7. Alvimedica Medical Technologies Inc.
  • 18.8. B. Braun Melsungen AG
  • 18.9. Balton Sp. z o.o.
  • 18.10. Biosensors International Group, Ltd.
  • 18.11. Biotronik SE & Co. KG
  • 18.12. Boston Scientific Corporation
  • 18.13. Cardinal Health, Inc.
  • 18.14. Cook Medical LLC
  • 18.15. Endocor GmbH
  • 18.16. Hexacath, Inc.
  • 18.17. JOTEC GmbH
  • 18.18. Medinol Ltd.
  • 18.19. Medtronic plc
  • 18.20. Merit Medical Systems, Inc.
  • 18.21. MicroPort Scientific Corporation
  • 18.22. Nipro Corporation
  • 18.23. Oscor Inc.
  • 18.24. QualiMed Innovative Medizinprodukte GmbH
  • 18.25. Teleflex Incorporated
  • 18.26. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BALLOON CATHETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BALLOON CATHETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BALLOON CATHETER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BALLOON CATHETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BALLOON CATHETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BALLOON CATHETER MARKET SIZE, BY CORONARY ANGIOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BALLOON CATHETER MARKET SIZE, BY PERIPHERAL CARDIAC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BALLOON CATHETER MARKET SIZE, BY PERIPHERAL CARDIAC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BALLOON CATHETER MARKET SIZE, BY PERIPHERAL CARDIAC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BALLOON CATHETER MARKET SIZE, BY NEUROVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BALLOON CATHETER MARKET SIZE, BY CAROTID ARTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BALLOON CATHETER MARKET SIZE, BY CAROTID ARTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BALLOON CATHETER MARKET SIZE, BY CAROTID ARTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BALLOON CATHETER MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BALLOON CATHETER MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BALLOON CATHETER MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BALLOON CATHETER MARKET SIZE, BY RENAL ARTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BALLOON CATHETER MARKET SIZE, BY RENAL ARTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BALLOON CATHETER MARKET SIZE, BY RENAL ARTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BALLOON CATHETER MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BALLOON CATHETER MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BALLOON CATHETER MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BALLOON CATHETER MARKET SIZE, BY OVER THE WIRE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BALLOON CATHETER MARKET SIZE, BY OVER THE WIRE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BALLOON CATHETER MARKET SIZE, BY OVER THE WIRE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BALLOON CATHETER MARKET SIZE, BY RAPID EXCHANGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BALLOON CATHETER MARKET SIZE, BY RAPID EXCHANGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BALLOON CATHETER MARKET SIZE, BY RAPID EXCHANGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BALLOON CATHETER MARKET SIZE, BY NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BALLOON CATHETER MARKET SIZE, BY NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BALLOON CATHETER MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BALLOON CATHETER MARKET SIZE, BY PEBAX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BALLOON CATHETER MARKET SIZE, BY PEBAX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BALLOON CATHETER MARKET SIZE, BY PEBAX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BALLOON CATHETER MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BALLOON CATHETER MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BALLOON CATHETER MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BALLOON CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BALLOON CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BALLOON CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BALLOON CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BALLOON CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BALLOON CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BALLOON CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BALLOON CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BALLOON CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BALLOON CATHETER MARKET SIZE, BY ABOVE 6 MILLIMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BALLOON CATHETER MARKET SIZE, BY ABOVE 6 MILLIMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BALLOON CATHETER MARKET SIZE, BY ABOVE 6 MILLIMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BALLOON CATHETER MARKET SIZE, BY 3 TO 6 MILLIMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BALLOON CATHETER MARKET SIZE, BY 3 TO 6 MILLIMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BALLOON CATHETER MARKET SIZE, BY 3 TO 6 MILLIMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BALLOON CATHETER MARKET SIZE, BY LESS THAN 3 MILLIMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BALLOON CATHETER MARKET SIZE, BY LESS THAN 3 MILLIMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BALLOON CATHETER MARKET SIZE, BY LESS THAN 3 MILLIMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BALLOON CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS BALLOON CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA BALLOON CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL BALLOON CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 143. GCC BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. GCC BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 146. GCC BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 147. GCC BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. GCC BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. GCC BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 167. G7 BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. G7 BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 170. G7 BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 171. G7 BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. G7 BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 173. G7 BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. G7 BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 175. NATO BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. NATO BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 178. NATO BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 179. NATO BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NATO BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 181. NATO BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. NATO BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA BALLOON CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA BALLOON CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA BALLOON CATHETER MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA BALLOON CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA BALLOON CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA BALLOON CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA BALLOON CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA BALLOON CATHETER MARKET SIZE, BY DIAMETER RANGE, 2018-2032 (USD MILLION)